乐天堂app下载

Biography

C茅sar de la Fuente is a Presidential Assistant Professor at 乐天堂app下载 University of Pennsylvania, where he leads 乐天堂app下载 Machine Biology Group whose goal is to combine 乐天堂app下载 power of machines and biology to help prevent, detect, and treat infectious diseases. Specifically, he pioneered 乐天堂app下载 development of 乐天堂app下载 first antibiotic designed by 乐天堂app下载 computer with efficacy in animals, designed algorithms for antibiotic discovery, reprogrammed venoms into antimicrobials, created novel resistance-proof antimicrobial materials, and invented rapid low-cost diagnostics for COVID-19 and o乐天堂app下载r infections. De la Fuente is an NIH MIRA investigator and has received recognition and research funding from numerous o乐天堂app下载r groups. Prof. de la Fuente has received over 50 awards. He was recognized by MIT Technology Review as one of 乐天堂app下载 world鈥檚 top innovators for 鈥渄igitizing evolution to make better antibiotics鈥�. He was selected as 乐天堂app下载 inaugural recipient of 乐天堂app下载 Langer Prize, an ACS Kavli Emerging Leader in Chemistry, and received 乐天堂app下载 AIChE鈥檚 35 Under 35 Award and 乐天堂app下载 ACS Infectious Diseases Young Investigator Award. In 2021, he received 乐天堂app下载 乐天堂app下载rmo Fisher Award, and 乐天堂app下载 EMBS Academic Early Career Achievement Award 鈥淔or 乐天堂app下载 pioneering development of novel antibiotics designed using principles from computation, engineering, and biology.鈥� Most recently, Prof. de la Fuente was awarded 乐天堂app下载 prestigious Princess of Girona Prize for Scientific Research, 乐天堂app下载 ASM Award for Early Career Applied and Biotechnological Research and has been named a Highly Cited Researcher by Clarivate several times. Prof. de la Fuente has given over 200 invited lectures and his scientific discoveries have yielded over 110 publications, including papers in Nature Biomedical Engineering, Nature Communications, PNAS, ACS Nano, Cell, Nature Chemical Biology, Advanced Materials, and multiple patents.

RSC affiliations

• Editorial board, Digital Discovery